Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes.
about
Current treatment options for type 2 diabetes mellitus in youth: today's realities and lessons from the TODAY studyOvernight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.Use of a food and drug administration-approved type 1 diabetes mellitus simulator to evaluate and optimize a proportional-integral-derivative controller.Closed-loop insulin delivery utilizing pole placement to compensate for delays in subcutaneous insulin deliveryA closed-loop artificial pancreas based on risk management.Probabilistic evolving meal detection and estimation of meal total glucose appearance.Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop systemSuspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump.New-generation diabetes management: glucose sensor-augmented insulin pump therapy.Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes.The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.Undeniable need for ultrafast-acting insulin: the pediatric perspectiveClosed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial.Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device.Past, present, and future of insulin pump therapy: better shot at diabetes control.Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming.Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.Moving toward the ideal insulin for insulin pumps.Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.Bolus Calculator Settings in Well-Controlled Prepubertal Children Using Insulin Pumps Are Characterized by Low Insulin to Carbohydrate Ratios and Short Duration of Insulin Action Time.Metabolic control of TYPE 1 Diabetes in children treated with insulin pump therapy.Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes.Mathematical modeling research to support the development of automated insulin-delivery systemsUpdate on mathematical modeling research to support the development of automated insulin delivery systems.Optimal prandial timing of bolus insulin in diabetes management: a review.Improved pharmacokinetic and pharmacodynamic profiles of insulin analogues using InsuPatch, a local heating device.Technology and Type 1 Diabetes: Closed-Loop Therapies
P2860
Q26863463-5BCD4F3E-E289-4021-A3C5-C05D261D0EB9Q30371580-98C0DA3D-C422-4DEC-9296-D55EFFEBAEB2Q30416614-A59A6F86-62BB-45EF-9334-3EAA98641D0BQ30424297-401F5350-552A-4EDA-896B-31EE7A3A84E8Q30428124-DA5A3FF9-A437-46E1-96F5-0DC9F1926990Q30434936-28BCBBCC-B63A-4B87-9A00-8A5C6A660809Q33740862-B403F2BF-5FE7-49BF-8404-FAD69CC35BEBQ34850888-AD416F75-C98D-41F1-86BB-DFFBDA30F16EQ35224968-D4B55DA9-6A82-42FB-9DBF-12F53CA6E170Q35682799-528B392C-032B-4E74-98B1-87E2651A991DQ35841209-990DD233-A969-4BFA-AD64-CBBDE42828A1Q36229282-4AF6E874-F5AE-43C1-99BD-9272B7207519Q36560323-708FF418-C0E0-4974-9EDA-63FD268E891BQ36609298-80400740-7A2C-41AD-B01F-0C2DF07BA80AQ36924597-BD54052F-8F8F-491C-BFD4-5499650D7EDEQ37067084-F2C0708D-5375-4368-AD63-952D7FF15046Q37404470-EEAAF53B-2C2C-44E7-9332-9C3433A3FA4FQ37460129-498C5298-BD55-4098-B4C2-AA81C473BCB6Q38205861-C671761A-3FF2-4E6E-8172-B44BE5378EEDQ38631154-33AC620E-22DC-47E9-8B78-17F125DE1AC5Q38811243-B7D29A2B-DBFB-488F-84F4-53EB88FA45F8Q39547766-FBE23765-8B7D-4FCD-ADE4-6FEC1378CB61Q42375658-39FD3159-F078-46BC-845A-A75BCDCA3BA9Q42555641-D38C3286-D137-43BA-A0F6-C69C90C78B5BQ42607729-F5BB13D8-14E0-4825-8671-CD730235244FQ42735600-03BE7CC4-30F2-470C-811E-FD9E1B7E7208Q47769561-D0933155-7C11-458B-AD1B-4C3E8F2FA807Q53603000-9E833D21-A75F-4509-9744-447D02E9023DQ55982188-1712EFB7-61B4-45E6-898B-AEE295E65C5E
P2860
Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Effect of puberty on the pharm ...... in youth with type 1 diabetes.
@en
Effect of puberty on the pharm ...... in youth with type 1 diabetes.
@nl
type
label
Effect of puberty on the pharm ...... in youth with type 1 diabetes.
@en
Effect of puberty on the pharm ...... in youth with type 1 diabetes.
@nl
prefLabel
Effect of puberty on the pharm ...... in youth with type 1 diabetes.
@en
Effect of puberty on the pharm ...... in youth with type 1 diabetes.
@nl
P2093
P356
P1433
P1476
Effect of puberty on the pharm ...... in youth with type 1 diabetes.
@en
P2093
Amy T Steffen
Garry M Steil
Gayane R Voskanyan
James D Dziura
Karena L Swan
Melody L Martin
Stuart A Weinzimer
P356
10.2337/DC07-0737
P407
P577
2007-10-01T00:00:00Z